Horse anti‐thymocyte globulin and eculizumab as concomitant therapeutic approach in an aplastic paroxysmal nocturnal hemoglobinuria patient: go or no‐go?

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0609|97|4|403-405

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.97, Iss.4, 2016-10, pp. : 403-405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : e27-e29

John Wiley & Sons Inc

Access to resources Recommend Favorite

A successful desensitization protocol for horse‐derived antithymocyte globulin in severe aplastic anemia

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 2, 2015-03 ,pp. : 168-172

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumab

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 11, 2015-11 ,pp. : 2004-2011

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epstein‐Barr virus‐induced polyclonal lymphoproliferative disorder of lymphoplasmacytic type in an autopsy case of aplastic anemia treated twice with anti‐thymocyte globulin therapy

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 5, 2015-05 ,pp. : 274-276

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal Involvement in Paroxysmal Nocturnal Hemoglobinuria

By  

Nephron Clin Pract, Vol. 123, Iss. 1-2, 2013-06 ,pp. : 28-35

Karger

Access to resources Recommend Favorite